Eric Weinberg serves as the Chief Commercial Officer at RxSight Inc., a leading medical technology company focused on developing and commercializing innovative solutions for cataract surgery. In his role, Weinberg is responsible for overseeing the company's global commercial strategy, sales, and marketing efforts. He plays a crucial role in driving the adoption of RxSight's flagship product, the Light Adjustable Lens (LAL) system, which allows for post-operative adjustments to optimize patients' vision after cataract surgery. Prior to joining RxSight, Weinberg held various leadership positions in the medical device industry. He spent over a decade at Abbott Medical Optics (now a part of Johnson & Johnson Vision), where he served as the Vice President of Sales and Marketing for the U.S. and Canada. During his tenure, he was instrumental in driving significant growth and market share gains for the company's cataract and refractive surgery portfolio. Weinberg's extensive experience in the ophthalmic industry, coupled with his strategic vision and leadership skills, have been invaluable assets to RxSight as the company continues to expand its presence in the global market. Under Weinberg's leadership, RxSight has made significant strides in increasing the adoption of the LAL system among ophthalmic surgeons and improving patient outcomes. His team has successfully launched targeted marketing campaigns and educational initiatives to raise awareness about the benefits of the LAL system, resulting in a growing network of trained surgeons and satisfied patients. Weinberg's dedication to innovation and his commitment to improving the quality of life for patients undergoing cataract surgery have been key drivers of RxSight's success, positioning the company as a leader in the rapidly evolving field of ophthalmic technology.